Abstract:
PURPOSE: Provided are the Gardeniae fructus extract having free radical scavenging activity and antiviral activity, novel compounds isolated therefrom and the use thereof for prevention and treatment of viral diseases, such as AIDS. CONSTITUTION: The Gardeniae fructus extract is obtained by extracting Gardeniae fructus with water or organic solvents. It contains as an active ingredent, methyl-0-caffeoyl-4-0-sinapolylquinate, methyl 3,5-0-dicarffeoyl-4-0-(3-hydroxy-3-methyl)glutaroylquinate, ethyl 5-0-caffeoyl-4-0-sinapoylquinate, methyl -0-caffeoyl--0-sinapoylquinate, ethyl 3-0-caffeoyl-5-0-sinapoylquinate, 3,5-0-dicaffeoylquinic acid, and 4,5-0-dicaffeoylquinic acid.
Abstract:
본 발명은 대사성 글루타메이트 수용체 서브타입 1에 길항제로 작용하여 대사성 글루타메이트 수용체 관련 질환, 즉 신경병성 통증과 편두통과 같은 통증, 불안장애나 정신분열증과 같은 정신질환, 요실금, 그리고 파킨스병이나 알츠하이머병과 같은 퇴행성 뇌질환 등에 약학적 활성을 보이는 사이에노피리미디논 유도체, 이들 화합물의 제조방법, 그리고 이들 화합물이 유효성분으로 함유된 약제조성물에 관한 것이다.
Abstract:
PURPOSE: A pharmaceutical composition containing 1,4-diazepane pyrazole compound and a pharmaceutically acceptable salt thereof is provided to be used as an agent for preventing or treating brain diseases, heart diseases, cancer, epilepsy, and pain. CONSTITUTION: A 1,4-diazepane pyrazole compound is denoted by chemical formula 1. A pharmaceutical composition for preventing and treating brain diseases such as epilepsy, depression, Parkinson's diseases, dementia, sleep disorders, or heart diseases such as hypertension, cardiac arrhythmia, or myocardial infarction, or pain contains the compound of chemical formula 1 as an active ingredient. A method for preparing the compound of chemical formula 1 comprises a step of reacting pyrazolemethyl amine of chemical formula 2 with chloroacetyl chloride.
Abstract:
PURPOSE: A pharmaceutical composition containing pyrazoyl piperidine compounds and pharmaceutically acceptable salt thereof is provided to prevent or treat brain diseases, heard diseases, cancer, and pain. CONSTITUTION: A pyrazoyl piperidine compound is denoted by chemical formula 1. A pharmaceutical composition for treating cerebral diseases, cardiac diseases, cancer, or pain contains the compound of chemical formula 1 as an active ingredient. A method for preparing the compound comprises: a step of reacting piperidine acetate of chemical formula 2 and pyrazole methyl amine of chemical formula 3 of a step of reacting piperidine compound of chemical formula 4 with an aldehyde compound of chemical formula 5 by reduction-amination. [Reference numerals] (AA) Reductive amination
Abstract:
PURPOSE: An antibacterial composition containing novel oxazolidinone derivative is provided to ensure antibacterial activity against gram positive bacteria. CONSTITUTION: A novel oxazolidinone derivative with antibacterial activity is denoted by chemical formula 1. A method for preparing the compound of chemical formula 1 or the salt thereof comprises: a step of reacting an amine group of a compound of chemical formula 2 with a compound of chemical formula 3 or 4; and a step of substituting a hydroxyl group of an oxazolidinone derivative or a pharmaceutically acceptable salt thereof with a halogen group or methoxy group. An antibacterial composition contains the oxazolidinone derivative of chemical formula 1 or a salt thereof as an active ingredient.
Abstract:
PURPOSE: A novel 1,6-disubstituted-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-7-one is provided to suppress cancer cells. CONSTITUTION: A 1,6-disubstituted-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-7-one compound is denoted by chemical formula 1. A pharmaceutical composition for anticancer contains the compound of chemical formula 1 or pharmaceutically acceptable salt thereof as an active ingredient. A method for preparing the compound of chemical formula 1 comprises a step of alkylating 3-amino compounds of chemical formula 2 with haloalkylcarbonyl piperazine of chemical formula 3 by alkylating.